|
PDSS2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.35549382618683E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.26360000241021E-09 |
| Normal-vs-Stage2 |
3.36869999995049E-06 |
| Normal-vs-Stage3 |
2.82669999962515E-07 |
| Normal-vs-Stage4 |
3.72429999999646E-05 |
| Stage1-vs-Stage2 |
9.076800E-01 |
| Stage1-vs-Stage3 |
4.270000E-01 |
| Stage1-vs-Stage4 |
5.593400E-01 |
| Stage2-vs-Stage3 |
4.905800E-01 |
| Stage2-vs-Stage4 |
5.048000E-01 |
| Stage3-vs-Stage4 |
9.600400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.74760214580283E-11 |
| Normal-vs-AfricanAmerican |
3.49099971153066E-10 |
| Normal-vs-Asian |
1.266030E-01 |
| Caucasian-vs-AfricanAmerican |
9.215800E-01 |
| Caucasian-vs-Asian |
7.997200E-01 |
| AfricanAmerican-vs-Asian |
7.884800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.49047482426113E-12 |
| Normal-vs-Female |
7.31829996603039E-09 |
| Male-vs-Female |
7.672000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.57359680841296E-11 |
| Normal-vs-Extreme_Weight |
3.4795499814777E-12 |
| Normal-vs-Obese |
9.55779999589623E-08 |
| Normal-vs-Extreme_Obese |
7.398800E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.911200E-01 |
| Normal_Weight-vs-Obese |
6.301600E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.502200E-02 |
| Extreme_Weight-vs-Obese |
1.047600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.208410E-01 |
| Obese-vs-Extreme_Obese |
5.300200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.54539999999803E-06 |
| Normal-vs-Age(41-60Yrs) |
3.76420006276135E-11 |
| Normal-vs-Age(61-80Yrs) |
1.23739996027439E-09 |
| Normal-vs-Age(81-100Yrs) |
5.08620000005955E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.246000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.945000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.495600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.607000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.350800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.105400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.83719714389008E-11 |
| Normal-VS-Type2 PRCC |
5.26400000033789E-07 |
| Normal-VS-KIRP CIMP |
1.44639999977159E-08 |
| Normal-VS-Unclassified PRCC |
6.05659999930452E-09 |
| Type1 PRCC-VS-Type2 PRCC |
9.357400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.638700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.766200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.613300E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
2.138400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.459900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.25099999645795E-08 |
| Normal-vs-N1 |
1.8062999984636E-09 |
| Normal-vs-N2 |
1.01130004370731E-09 |
| N0-vs-N1 |
2.847000E-01 |
| N0-vs-N2 |
3.402600E-04 |
| N1-vs-N2 |
1.992180E-01 |
|
|
